Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (14 quarters reported)
$1.9B in Q2 2013 → — now. Hover for any quarter.
As reported for the quarter ended September 30, 2016. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| N N/a | NaN% | Unchanged | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2016 · filed November 16, 2016
No position changes this quarter.
quarter ended June 30, 2016 · filed August 12, 2016
No position changes this quarter.
quarter ended March 31, 2016 · filed May 09, 2016
No position changes this quarter.
quarter ended December 31, 2015 · filed February 16, 2016
No position changes this quarter.
quarter ended September 30, 2015 · filed November 16, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| MV Market Vectors ETF Tr | Exited | −1,273,300 | −$22.6M | — |
| N N/a | New | +0 | — | — |
quarter ended June 30, 2015 · filed August 14, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| MV Market Vectors ETF Tr | Added | +456,821 | +$8.11M | 100.0% |
quarter ended March 31, 2015 · filed May 15, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CD Cadence Design System Inc | Exited | −47,857,000 | −$120M | — |
| Supernus Pharmaceuticals Inc | Exited | −10,708,000 | −$18.6M | — |
| MV Market Vectors ETF Tr | New | +816,479 | +$14.9M | 100.0% |
quarter ended December 31, 2014 · filed February 17, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Sba Communications Corp | Exited | −270,003,000 | −$977M | — |
| CD Cadence Design System Inc | Trimmed | −58,475,000 | −$147M | 86.6% |
| Gilead Sciences Inc | Exited | −14,631,000 | −$68.3M | — |
| A Akorn Inc | Exited | −4,991,000 | −$20.7M | — |
| Supernus Pharmaceuticals Inc | New | +10,708,000 | +$18.6M | 13.4% |
| Supernus Pharmaceuticals Inc | Exited | −1,144,514 | −$9.95M | — |
| Carrols Restaurant Group Inc | Exited | −50,000 | −$356K | — |
Loading...
